Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Gabapentin market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Gabapentin Market by XYZResearch Include
- China
- EU
- North America
- Japan
- India
- Southeast Asia
- South America
- Middle East and Africa
Competitive Analysis; Who are the Major Players in Gabapentin Market?
- Pfizer
- GSK
- Sailike
- Jiangsu Enhua
- Jiangsu Hengrui
- Novartis
- Actavis
- Glenmark
Major Type of Gabapentin Covered in XYZResearch report:
- Tablet
- Capsule
Application Segments Covered in XYZResearch Market
- Nerve Pain
- Restless Legs Syndrome
- Seizures
For any other requirements, please feel free to contact us and we will provide you customized report.
Post-pandemic Era - Global Gabapentin Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
Table of Contents
Global Gabapentin Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Tablet -Product Introduction and Major Manufacturers
1.1.2 Capsule -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Gabapentin Status and Prospect (2015-2026)
2.1.1 China Gabapentin Market Size and Growth Rate (2015-2026)
2.1.2 China Gabapentin Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Gabapentin Status and Prospect (2015-2026)
2.2.1 EU Gabapentin Market Size and Growth Rate (2015-2026)
2.2.2 EU Gabapentin Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Gabapentin Status and Prospect (2015-2026)
2.3.1 USA Gabapentin Market Size and Growth Rate (2015-2026)
2.3.2 USA Gabapentin Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Gabapentin Status and Prospect (2015-2026)
2.4.1 Japan Gabapentin Market Size and Growth Rate (2015-2026)
2.4.2 Japan Gabapentin Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Gabapentin Status and Prospect (2015-2026)
2.5.1 India Gabapentin Market Size and Growth Rate (2015-2026)
2.5.2 India Gabapentin Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Gabapentin Status and Prospect (2015-2026)
2.6.1 Southeast Asia Gabapentin Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Gabapentin Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Gabapentin Status and Prospect (2015-2026)
2.7.1 South America Gabapentin Market Size and Growth Rate (2015-2026)
2.7.2 South America Gabapentin Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Gabapentin Status and Prospect (2015-2026)
2.8.1 Gabapentin Market Size and Growth Rate (2015-2026)
2.8.2 Gabapentin Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Gabapentin Market Assessment by Segment
3.1 Global Gabapentin Capacity and Growth Rate
3.2 Global Gabapentin Sales by Type
3.3 Global Gabapentin Sales Revenue by Type
3.4 Global Gabapentin Consumption by Application
4 Global Gabapentin Market Assessment by Regions
4.1 Global Gabapentin Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Gabapentin Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Gabapentin Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Gabapentin Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Gabapentin Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Gabapentin Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Gabapentin Sales Market Share of Manufacturers (2019-2020)
6.3 Global Gabapentin Sales Revenue Market Share of Manufacturers (2019-2020)
7 Gabapentin Competitive Analysis
7.1 Pfizer
7.1.1 Pfizer Company Profiles
7.1.2 Pfizer Product Introduction
7.1.3 Pfizer Gabapentin Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 GSK
7.2.1 GSK Company Profiles
7.2.2 GSK Product Introduction
7.2.3 GSK Gabapentin Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Sailike
7.3.1 Sailike Company Profiles
7.3.2 Sailike Product Introduction
7.3.3 Sailike Gabapentin Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Jiangsu Enhua
7.4.1 Jiangsu Enhua Company Profiles
7.4.2 Jiangsu Enhua Product Introduction
7.4.3 Jiangsu Enhua Gabapentin Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Jiangsu Hengrui
7.5.1 Jiangsu Hengrui Company Profiles
7.5.2 Jiangsu Hengrui Product Introduction
7.5.3 Jiangsu Hengrui Gabapentin Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Novartis
7.6.1 Novartis Company Profiles
7.6.2 Novartis Product Introduction
7.6.3 Novartis Gabapentin Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Actavis
7.7.1 Actavis Company Profiles
7.7.2 Actavis Product Introduction
7.7.3 Actavis Gabapentin Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Glenmark
7.8.1 Glenmark Company Profiles
7.8.2 Glenmark Product Introduction
7.8.3 Glenmark Gabapentin Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
8 Conclusion
List of Tables and Figures
Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Gabapentin Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Gabapentin Sales (K Unit) by Type (2015-2026)
Figure Global Gabapentin Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Gabapentin Sales Market Share (%) by Type (2019 -2020)
Table Global Gabapentin Sales Value (Million USD) by Type (2015-2026)
Figure Global Gabapentin Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Gabapentin Sales Value Market Share (%) by Type (2019-2020)
Table Global Gabapentin Sales (K Unit) by Application (2015-2026)
Figure China Gabapentin Production Value (Million USD) and Growth Rate (2015-2026)
Table China Gabapentin Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Gabapentin Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Gabapentin Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Gabapentin Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Gabapentin Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Gabapentin Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Gabapentin Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Gabapentin Production Value (Million USD) and Growth Rate (2015-2026)
Table India Gabapentin Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Gabapentin Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Gabapentin Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Gabapentin Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Gabapentin Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Gabapentin Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Gabapentin Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Gabapentin Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Gabapentin Capacity (K Units) and Growth Rate (2015-2026)
Table Global Gabapentin Sales (Unit) by Type (2015-2026)
Figure Global Gabapentin Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Gabapentin Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Gabapentin Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Gabapentin Consumption (Unit) by Application (2015-2026)
Figure Global Gabapentin Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Gabapentin Production (K Unite) by Regions (2015-2020)
Table Global Gabapentin CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Gabapentin Production Share by Regions (2019-2020)
Table Global Gabapentin Sales (K Unite) by Regions (2015-2020)
Table Global Gabapentin CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Gabapentin Sales Share by Regions (2019-2020)
Table Global Gabapentin Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Gabapentin CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Gabapentin Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Gabapentin
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Gabapentin
Figure Cost Structure of Gabapentin in 2020
Table Global Gabapentin Capacity Share of Manufacturers (2019-2020)
Figure Global Gabapentin Capacity Share of Manufacturers (2019-2020)
Table Global Gabapentin Sales Market Share of Manufacturers (2019-2020)
Figure Global Gabapentin Sales Market Share of Manufacturers (2019-2020)
Table Global Gabapentin Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Gabapentin Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Gabapentin Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table Pfizer Profiles
Table Pfizer Gabapentin Product Introduction
Table Pfizer Gabapentin Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Pfizer SWOT Analysis
Table GSK Profiles
Table GSK Gabapentin Product Introduction
Table GSK Gabapentin Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure GSK SWOT Analysis
Table Sailike Profiles
Table Sailike Gabapentin Product Introduction
Table Sailike Gabapentin Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Sailike SWOT Analysis
Table Jiangsu Enhua Profiles
Table Jiangsu Enhua Gabapentin Product Introduction
Table Jiangsu Enhua Gabapentin Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Jiangsu Enhua SWOT Analysis
Table Jiangsu Hengrui Profiles
Table Jiangsu Hengrui Gabapentin Product Introduction
Table Jiangsu Hengrui Gabapentin Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Jiangsu Hengrui SWOT Analysis
Table Novartis Profiles
Table Novartis Gabapentin Product Introduction
Table Novartis Gabapentin Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Novartis SWOT Analysis
Table Actavis Profiles
Table Actavis Gabapentin Product Introduction
Table Actavis Gabapentin Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Actavis SWOT Analysis
Table Glenmark Profiles
Table Glenmark Gabapentin Product Introduction
Table Glenmark Gabapentin Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Glenmark SWOT Analysis
Global Restless Legs Syndrome Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 112
According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product di......
Global Autism Spectrum Disorder Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 110
Report Overview:
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child's behavior and development to make a diagnosis. Our report studies the market......
Global Epilepsy Therapeutics Market Research Report 2023
Published: 14-Dec-2023 Price: US 2900 Onwards Pages: 86
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Therapeutics market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Laboratories
- Cephalon
- Novartis
- Pfizer
- Johnson & Johnson
- GlaxoSmithKline
- Sanofi
- Sunovion Pharmaceuticals......
Global Autism Spectrum Disorder Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 109
Market Overview of Global Autism Spectrum Disorder market:
According to our latest research, the global Autism Spectrum Disorder market looks promising in the next 5 years. As of 2022, the global Autism Spectrum Disorder market was estimated at USD 464.19 million, and it's anticipated to reach USD 700.88 million in 2028, with a CAGR of 7.11% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
Global Autism Spectrum Disorder Market Status and Outlook 2023-2028
Published: 24-Nov-2023 Price: US 3160 Onwards Pages: 109
Autism spectrum disorder (ASD) is a complex developmental condition that involves persistent challenges in social interaction, speech and nonverbal communication, and restricted/repetitive behaviors. The effects of ASD and the severity of symptoms are different in each person.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segmen......
Global Epilepsy Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 112
Market Overview of Global Epilepsy Therapeutics market:
According to our latest research, the global Epilepsy Therapeutics market looks promising in the next 5 years. As of 2022, the global Epilepsy Therapeutics market was estimated at USD 11157.84 million, and it's anticipated to reach USD 13510.46 million in 2028, with a CAGR of 3.24% during the forecast years.
Epilepsy is a group of neurological disorders characterized by seizures. The onset of a seizure can range from a b......
Global Gabapentin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 12-Oct-2023 Price: US 3380 Onwards Pages: 98
Market Overview of Global Gabapentin market:
According to our latest research, the global Gabapentin market looks promising in the next 5 years. As of 2022, the global Gabapentin market was estimated at USD 1627.13 million, and it's anticipated to reach USD 1844.92 million in 2028, with a CAGR of 2.12% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gabapentin market, with a sys......
2023-2031 Report on Global Autism Spectrum Disorder Market by Player, Region, Type, Application and Sales Channel
Published: 09-Oct-2023 Price: US 2500 Onwards Pages: 89
This report studies the Autism Spectrum Disorder market, covering market size for segment by type (Center-Based, In-Home, etc.), by application (1-14 Years Old, 15-25 Years Old, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Otsuka, Astrazeneca, Pfizer, Eli Lilly, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Aut......
Global Gabapentin Market Insights, Forecast to 2029
Published: 27-Sep-2023 Price: US 4900 Onwards Pages: 112
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The global Gabapentin market is projected to grow from US$ 1572.1 million in 2023 to US$ 1749.7 million by 2029, at a Compound Annual Growth Ra......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
